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Abstract 
Objectives: Transitioning into palliative care is psychologically demanding for people with advanced cancer, and 
there is a need for acceptable and effective interventions to support this. We aimed to develop and pilot test a brief 
Acceptance and Commitment Therapy (ACT) based intervention to improve quality of life and distress.
Methods: Our mixed‑method design included: (i) quantitative effectiveness testing using Single Case Experimental 
Design (SCED), (ii) qualitative interviews with participants, and (iii) focus groups with hospice staff. The five‑session, 
in‑person intervention was delivered to 10 participants; five completed at least 80%.
Results: At baseline, participants reported poor quality of life but low distress. Most experienced substantial physical 
health deterioration during the study. SCED analysis methods did not show conclusively significant effects, but there 
was some indication that outcome improvement followed changes in expected intervention processes variables. 
Quantitative and qualitative data together demonstrates acceptability, perceived effectiveness and safety of the 
intervention. Qualitative interviews and focus groups were also used to gain feedback on intervention content and to 
make design recommendations to maximise success of later feasibility trials.
Conclusions: This study adds to the growing evidence base for ACT in people with advanced cancer. A number 
of potential intervention mechanisms, for example a distress‑buffering hypothesis, are raised by our data and these 
should be addressed in future research using randomised controlled trial designs. Our methodological recommenda‑
tions—including recruiting non‑cancer diagnoses, and earlier in the treatment trajectory—likely apply more broadly 
to the delivery of psychological intervention in the palliative care setting.
This study was pre‑registered on the Open Science Framework (Ref: 46,033) and retrospectively registered on the 
ISRCTN registry (Ref: ISRCTN12084782).
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Introduction
Cancer is the second most common cause of death glob-
ally, responsible for 9.6 million deaths in 2018 [1]. By 
2030, an estimated 4 million people will be living with or 
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beyond cancer in the UK [2], and the number of people 
requiring palliative care is expected to rise substantially 
[3].
Palliative care aims to maintain quality of life and ease 
physical and psychological symptom burden. NICE qual-
ity standards for adults approaching end of life includes 
holistic care, encompassing psychological, emotional, 
and social support [4]. Despite this, people with advanced 
cancer experience significant psychological and social 
distress [5, 6]. Transition points, such as that into pallia-
tive care, can be particularly psychologically demanding 
as patients adjust to altered life expectations [7, 8]. This 
can impact their ability to plan for the future and willing-
ness to engage in advance care planning.
Acceptance and Commitment Therapy (ACT) is a psy-
chological intervention that may support cancer patients 
approaching end of life. ACT aims not to change or 
reduce distressing thoughts, but to coach ways of limiting 
the influence of those thoughts and feelings on day-to-
day living and goal achievement by increasing psycho-
logical flexibility [9]. ACT acknowledges that distress and 
suffering are normal, rational reactions to challenging life 
events. Techniques such as mindfulness, acceptance, and 
values identification help people to direct their behav-
iours towards living in the present moment rather than 
focusing on fears or anxieties. ACT can support people 
to cope with feelings of grief and demoralisation which 
may improve quality of life and sense of meaning [10].
ACT has a growing evidence-base in cancer [11], with 
acceptability indicated in those with advanced disease 
[12]. In one trial comparing ACT and cognitive behav-
ioural therapy in patients with advanced ovarian can-
cer, ACT was associated with improved quality of life 
and reduced distress [13]. In more recent pilot studies, 
ACT was (non-significantly) associated with decreased 
symptom interference [14], and significantly improved 
sleep, distress and hyperarousal [15]. UK-based research 
reports that it is feasible to deliver ACT to people with 
advanced cancer, but concluded that more work is 
needed to robustly test efficacy [16].
Our objectives were to develop and test acceptabil-
ity and potential efficacy of a brief ACT-based coaching 
intervention to support people with an incurable cancer 
diagnosis, at the point of referral to a hospice service. 
As a secondary aim, our study modelled psychological 
mechanisms (i.e. psychological flexibility) as a vital first 
step in fully evaluating ACT as a complex intervention 
for palliative care.
Method
The design, including intervention development, has 
been reported previously [17]. All study protocols 
received ethical and research governance approvals from 
the UK Health Research Authority (Ref: 18/WA/0087). 
The study was pre-registered on the Open Science 
Framework (Ref: 46,033; Date Registered 12/06/2018) 
and retrospectively registered on the ISRCTN registry 
(Ref: ISRCTN12084782; Date Registered 31/01/2021). 
Study methods were carried out in accordance with prin-
ciples for medical research involving human subjects as 
laid down in the World Medical Association Declaration 
of Helsinki.
Design
A mixed-methods design was used, as is recommended 
for trial development [18]. Patient and stakeholder 
engagement featured heavily to maximise acceptability 
and implementation [19]. To assess initial effectiveness, 
we used a single-case experimental design (SCED) [20], 
allowing for highly controlled delivery alongside patient-
centred, in-depth, analysis [21]. SCEDs are experimen-
tal designs where the efficacy of an intervention can be 
closely examined, with each participant providing their 
own ‘control’ data by completing comprehensive meas-
urement prior to, during, and after implementation of the 
intervention. Frequent, repeated measurement of process 
and outcome lend themselves to a mode of within-par-
ticipant analysis that can be conducted on a very small 
number of participants. SCEDs are common in psycho-
logical intervention research and have established utility 
in cancer research [22, 23]. Though not designed as a fea-
sibility trial, the design permitted piloting recruitment, 
intervention and data collection methods.
Participants
Anyone over 16 years of age at the point of referral into 
specialist hospice care at recruitment sites (one in Eng-
land; two in Scotland) following an incurable cancer 
diagnosis was eligible. Recruitment took place between 
May 2018 and March 2019. Study invitation took place 
during the participant’s initial appointment with the hos-
pice specialist nurse.
High attrition was expected given prognosis [24]; 
accordingly, we excluded those with less than four 
months life expectancy to maximise trial completion 
likelihood. We aimed to recruit 20 people, expecting a 
50% intervention completion rate. Given that SCED is 
an idiographic, within-participants approach, this is suf-
ficient for our study aims [25, 26].
Intervention
The Brief Engagement and Acceptance Coaching for 
Hospice Settings (BEACHeS) Intervention contained five 
in-person, one-to-one sessions, each lasting 40–60  min 
(Table  1). Following an initial assessment, ACT con-
tent was delivered over three subsequent sessions, 
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approximately one week apart. The fifth session, one 
month later, consolidated and maintained gains, and 
problem-solved difficulties. In-person work was supple-
mented with home-practice and exercises. Written ses-
sion summaries were provided to support change and 
encourage sharing of content with significant others.
In developing the manual we selected exercises and 
metaphors that were suitable for participants with a non-
curative cancer diagnosis. For example, we avoided those 
exercise and metaphors common to other ACT inter-
vention manuals that involve the participant consider-
ing their future life choices, instead developing tailored 
metaphors more appropriate to those who may be close 
to the end of life (see our published protocol for more 
detail) [17]. The manual was peer-reviewed by five inde-
pendent ACT or palliative care experts.
The intervention was designed to be delivered by 
appropriately trained Clinical Psychologists or BABCP 
accredited psychological therapists to enable optimal 
experimental control, and to establish manual safety 
prior to delivery by other healthcare professionals in 
future trials. Two intervention facilitators were appointed 
and their competency independently assessed against 
published criteria [27] using video-simulation. Supervi-
sion was provided by a Clinical Psychologist and delivery 
audio-recorded for fidelity checking.
By developing an intervention that is both brief and 
manualised, we aimed to optimise long term cost-effec-
tiveness and implementation possibilities.
Procedure and outcome assessments
Eligibility screening was undertaken by hospice-based 
community specialist nurses who provided study infor-
mation and gained verbal consent to refer patients to the 
research team. A researcher then contacted participants 
by telephone to arrange the initial assessment session, 
where informed consent was taken and baseline meas-
ures assessed. These measures were repeated prior to 
each subsequent intervention session:
Primary outcome: quality of life
Administration of the Functional Assessment of Chronic 
Illness Therapy (Palliative Care) [28] provided primary 
outcome data. This scale comprises five quality of life 
domains—physical (7 items), social/family (7 items), 
emotional (6 items), functional (7 items) and addi-
tional concerns (19 items)—each scored on a scale of 
0 (anchored to poorer quality of life) to 4 (anchored to 
better quality of life). Participants answer based on their 
experiences over the previous seven days.
Secondary outcomes: distress
Distress was assessed using the single-item Distress 
Thermometer [29], a commonly used screening tool in 
cancer settings (score range 0 to 10; higher ratings rep-
resent worse distress). Participants indicate their distress 
level over the previous seven days.
Postulated Intervention mechanism: psychological flexibility
Psychological flexibility was assessed using the 23-item 
Comprehensive Assessment of Acceptance & Commit-
ment Therapy (CompACT) [30]; separate component 
scores—openness to experience, behavioural awareness 
and valued action—map closely to the three core inter-
vention sessions making this ideal for our study. Subscale 
scores range from 0 to 42, with higher scores represent-
ing greater psychological flexibility.
Daily assessments
Daily recordings of key process and outcome meas-
ures are integral to SCED studies and were assessed 
using either a smart-phone based app (PACO: Personal 
Table 1 Outline of intervention content
a  The workability module was delivered to all participants at the start of session 2, however, the modular format allowed for awareness, openness and engagement to 
be delivered in whichever order was most appropriate for each participant [19]
Session Purpose Content
1 Module A: Assessment 
& Engagement
Warmth, empathy, positive regard. History taking, typical responses to transition, beginning baseline monitoring 
and introducing measurement protocol and concepts
2–4 Module B:  Workabilitya Review of typical responses to distress/suffering and greater contact with the consequences, linking ineffective 
strategies with control, avoidance and cognitive fusion
Module C: Awareness Teaching awareness skills, linking to greater behavioural choice, mindfulness exercises, 5 senses experience, mindful 
eating a raisin, 10‑min mindfulness audio exercise given for homework
Module D: Openness Demonstrating the greater effectiveness of willingness to have difficult thoughts and feelings and at the same time, 
stepping back from such inner experiences
Module E: Engagement Linking behavioural effectiveness with desired outcomes and qualities of actions, in order to live with purpose and 
meaning
5 Module F: Follow‑up Review of progress, barriers to practice, anticipation of future challenges and how ACT skills could be used, behav‑
ioural rehearsal of effective responses, commitments to next steps. Ending contact
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Analytics Companion) or paper-and-pen alternative. 
Participants completed the Brief Acceptance Measure 
(BAM) [31], a three-item measure of psychological flex-
ibility (score range 0–30 where high scores indicate 
greater flexibility), and a single quality of life question 
where participants indicated their current overall health 
from 0 (worst imaginable) to 100 (best imaginable). All 
daily assessments ask participants to provide a rating 
based on how they were feeling on that particular day.
Qualitative data
Participants who completed the intervention, or actively 
withdrew, were invited to a qualitative interview. A 
choice of telephone or in-person interview (at the hos-
pice) was offered. The interview schedule aimed to eluci-
date experiences of study participation, acceptability and 
perceived intervention effectiveness. Debrief information 
was provided on study completion.
After closing recruitment, staff involved at each sites 
were invited to a focus group discussion about challenges 
and barriers to recruiting participants and supporting 
the study in the hospice setting. We also sought opin-
ions about different study designs for follow-on research. 
Interviews and focus groups were audio-recorded and 
transcribed verbatim for analysis.
Analysis
In this paper we focus on participants meeting inter-
vention completion criteria, defined as completion of at 
least four (80%) intervention sessions. Missing data was 
not imputed. Consistent with SCED best-practice [32], 
daily assessment data was analysed using visual analysis 
and within-case statistical analysis. Visual analysis was 
performed using the SCED Package for R [33]. This uses 
ordinary least squares regression to create trend lines 
and Median Absolute Deviation to provide a standard-
ized visualization of data spread, which are considered an 
advancement on other visual analysis strategies [34, 35]. 
Aligned with the idiographic nature of SCED research, 
we refer to participants using pseudonyms throughout 
our results.
Tau-U tests determined statistical significance of data 
overlap between variance envelopes and independence of 
trend lines between the baseline phase (session 1 though 
to session 2), the active intervention phase (Session 2 
through to one week after Session 4), and follow-up (up 
until to session 5), whilst controlling for baseline trend 
[26]. Due to the small sample, weekly assessment data 
was analysed using descriptive methods only.
Participant interview data was analysed thematically 
[36]. Focus group data was analysed using a framework 
approach to allow for a structured approach to address 
study aims [37].
Results
Recruitment took longer than anticipated and after nine 
months only 10 participants had consented. Only 15.2% 
of hospice referrals met eligibility criteria, and just 19.2% 
of those consented (Fig. 1).
The five participants (50%) who completed the inter-
vention provided a sufficient sample size for SCED analy-
sis, in which successful delivery to three participants is 
Fig. 1 Recruitment, eligibility and attrition
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considered a minimum to demonstrate reliability of effect 
[38]. Outcome measure completion was high: no partici-
pants missed data on weekly measures, half completed 
97% or more daily assessment points (two non-com-
pleters failed to engage with daily assessments entirely). 
Only one participant opted for smart-phone based daily 
data collection.
Of the participants who did not complete the inter-
vention, one withdrew, and four died part-way through 
(Table 2).
Compared to previous literature, our sample reported 
poorer baseline quality of life [28]. Intervention com-
pleters were slightly below threshold for clinically-signifi-
cant distress (< 4) at baseline [39]. Physical and functional 
quality of life were lower in non-completers indicating 
poorer baseline health status (Table 3).
Intervention effectiveness
Visual analysis highlights problematic ceiling and floor 
effects in daily BAM and single-item QoL assessments 
(Fig.  2). Additionally, baseline periods lacked ideal lev-
els of stability, and there was little distinction between 
experimental phases (baseline to intervention and inter-
vention to follow-up). Weekly assessments offered more 
assessment sensitivity and variability over time.
Elizabeth, Andrew, and Graham all showed deterio-
rating quality of life during baseline; for both Elizabeth 
and Andrew this then stabilized and improved during 
the intervention. Tau-U analysis (Table 4) confirmed this 
improvement was significant in only one case (Elizabeth). 
The lack of further significant change from intervention 
to follow-up indicates that gains were maintained. James 
and Michelle reported non-significant decreasing quality 
of life through the intervention.
Elizabeth’s data demonstrates a ceiling effect on 
the BAM. Both James and Graham reported decreas-
ing psychological flexibility, and in James’s case this 
was significant throughout. Andrew reported a non-
significant increase in psychological flexibility from 
baseline to intervention, and Michelle demonstrated sig-
nificant improvement in psychological flexibility occur-
ring between intervention and follow-up.
Weekly assessment change scores (Fig. 3) demonstrate 
stability in distress for four participants, and improve-
ment for the fifth; for some (e.g. Elizabeth) there was a 
measurement ceiling-effect which prevented improve-
ment being recorded. Four showed improvement in at 
least some quality of life sub-domains, however two par-
ticipants (Graham, Michelle) demonstrate a considerable 
decrease through follow-up. For Michelle, more so than 
Graham, it is encouraging that distress and psychosocial 
quality of life stayed stable, even though physical health 
deteriorated.
Two participants (James, Andrew) demonstrated a 
clear mapping of improvement of sub-components of 
psychological flexibility (openness, awareness, engage-
ment) following delivery of those specific modules, and 
this is consistent with the pattern of outcome improve-
ments too.
The sample is too small for confident conclusions to 
be drawn, but there is some evidence that increased 
psychological flexibility maps closely onto buffering dis-
tress increases and maintaining psychosocial quality of 
life, even where physical and functional quality of life 
deteriorated.
Qualitative feedback
Three intervention completers took part in interviews, 
and fifteen staff took part in focus groups. These quali-
tative data are described in three themes: intervention 
effectiveness, intervention acceptability, and suggestions 
for future research.
Perceived intervention effectiveness
All participants reported benefits from taking part, 
including facing the reality of end of life:
“…I wasn’t sure whether I would die with dignity…he 
helped me through that.” (James)
And being able to discuss fears and emotions honestly:
“…you can sit and talk and you’re not holding any-
thing back…somebody different to your family…” 
(Graham)
Participants describe using the coping skills taught out-
side of the intervention sessions:
“…it was the meditation part of it. Yeah. Mhhm 
because I used to do that quite a lot… And it was 
yeah, it was really good…the other night I used it to 
get to sleep.” (Elizabeth).
The intervention helped participants to accept their 
current circumstances:
“I always had this mental picture of lying on my 
death bed surrounded by my family and I realised 
that that wasn’t going to happen, you know. And 
he worked me through my feelings with that one.” 
(James).
Staff involved in focus groups reported positive percep-
tions too, based on their conversations with participants:
“…he only made it to two sessions, two or three, and 
he had a great benefit…his wife noticed a difference 
as well…she felt that he was definitely…lighter when 
he came back from session.” (FG2)
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Table 2 Participant (pseudonym) characteristics and intervention engagement
Participant Clinical description Engagement / session order
Intervention completers
 Elizabeth 58 year old single woman, with breast cancer. Elizabeth moved in 
with her sister during treatment, fearful of loss of independence 
and mobility. Her distress levels were low when she entered the 
intervention. At the time of referral she was undergoing palliative 
chemotherapy. She accessed orthopaedic services to discuss 
surgical options for her symptoms. Clinical data indicated that 
after a good chemotherapy response, Elizabeth was discharged 
from hospice community services 10 months after referral
Session 1: Module A
Session 2: Module B & C
Session 3: Module D
(3 week gap)
Session 4: Module E
Session 5: Module F
Interview: 7 weeks later
 James 81 year old widower, with oesophageal cancer. James had grown 
children living locally, with grandchildren. He was receiving pal‑
liative radiotherapy. James was moderately distressed, reviewing 
life meaning. He continued to have active engagement with a 
variety of hospice support services
Session 1: Module A
Session 2: Module B & D
Session 3: Module E
Session 4: Module C
Session 5: Module F
Interview 13 weeks later
 Graham 66 year old with oesophageal cancer and chronic obstructive pul‑
monary disorder. Graham was living with a supportive partner, 
and had children in other parts of the UK. He was not especially 
distressed but low in mood at times. Graham continued to 
access hospice day services
Session 1: Module A
Session 2: Module B & C
Session 3: Module D
Session 4: Module E
Session 5: Module F
Interview 2 weeks later
 Andrew 73 year old man with prostate cancer. He had a supportive wife 
and grown children. Andrew stopped conventional treatment 
when he was referred to hospice care. Overwhelmed by his 
diagnosis, and distressed, he accessed mainly emotional and 
psychological support. Other services used included occupa‑
tional therapy
Session 1: Module A
Session 2: Module B & E
Session 3: Module D
Session 4: Module C
Withdrew 3 weeks later
 Michelle 46 year old woman with cervical cancer. She had a long history of 
interpersonal difficulties, relatively chaotic lifestyle, and previous 
episodes of psychological problems which were now stable. 
Michelle had completed palliative chemotherapy and sought 
emotional and benefits advice. She appeared avoidant of think‑
ing of her illness
Session 1: Module A
Session 2: Module B & C
Session 3: Module D
Session 4: Module E
Session 5: Module F
(Over an extended 13 week period)
Withdrawn or deceased participants
 Sally 48 year old woman with lung cancer. Sally had children and young 
grandchildren, and was supported by her husband. At the time 
of entering the intervention, she was moderately distressed. Sally 
was receiving only palliative treatment and died 4 months after 
referral to the hospice. She had received visits from the hospice 
nursing service, but did not access any other hospice support or 
care services
Session 1: Module A
Session 2: Module B & C
Formally withdrew from study 11 weeks after this, and died two 
weeks later
 Mary 73 year old woman, with pancreatic cancer. She had a long history 
of psychological difficulties, although her mental health was cur‑
rently stable. Mary was living alone, supported by her daughter. 
She appeared resilient throughout her time in the study. She was 
being cared for with ongoing pain and symptom management 
and in addition to hospice nurse visits, she accessed benefit 
support and diabetic nurse care. Mary died almost three months 
after her referral into hospice services
Session 1: Module A
Session 2: Module B & C
Withdrew from study the following week, and died five weeks later
 John 71 year old man with bladder cancer, who was undergoing pallia‑
tive chemotherapy. He had increasing levels of pain and nausea 
and became socially withdrawn when told his cancer wasn’t 
curable. After two sessions he withdrew from the study because 
he decided to return to work. John was admitted to hospital five 
months after referral into hospice community services. He died 
in hospital a few weeks later
Session 1: Module A
Session 2: Module B & C
Withdrew from study five weeks later
 Daniel 69 year old man, with cancer of the digestive organs and perito‑
neum. Daniel was married, with grown children, and was well 
supported by his wife. Daniel became increasingly unwell over 
a short period time following hospitalisation for a suspected 
infection. He was receiving palliative treatment for pain, fatigue 
and agitation. Daniel died at home seven weeks after referral to 
hospice community services
Session 1: Module A
Withdrew from the study before Session 2
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Intervention acceptability
Patients found the intervention acceptable, with partici-
pants responding positively about intervention content. 
Intervention length was thought appropriate by all but 
one participant (who expressed a preference for a shorter 
intervention); they warned that expecting more would 
have been difficult due to the challenge of deteriorating 
health:
“I found them just the right…I don’t think I could 
have went any longer.” (Graham)
There was some variation in opinions around preferred 
metaphors:
“…it’s just not the way that I think…other people it 
might be, but not me.” (Elizabeth)
And some participants suggested that the intervention 
might benefit more people if the language was simplified.
“I don’t know whether I was rationalising it, I don’t 
know, but I put my difficulty down to age. Compre-
hension, you know, trying to comprehend…I think 
a lot of people would get benefit if it was just tem-
pered down a wee bit.” (James).
Patients were supportive of delivering the interven-
tion in the hospice setting:
“…certainly much more convenient, it’s a conducive 
environment as well…it’s nice that you can come to 
this protected environment…” (James)
And their views on offering the intervention at this 
specific transition point into palliative care were also 
positive:
“I would say it would be the best time. Cause peo-
ple can get into a mindset if you leave it too long 
and they’ll never get out of it. So if you get them at 
the beginning…get there quick.” (Elizabeth)
Reference here to ‘the beginning’ might also support 
a move to earlier recruitment in the care pathway, given 
that the boundary between curative and palliative care 
is also moving earlier.
Table 2 (continued)
Participant Clinical description Engagement / session order
 Michael 72 year old man, diagnosed with colon cancer and liver metas‑
tases. Michael was living with his wife, and with children and 
grandchildren. Michael was relatively accepting, with low levels 
of distress throughout the intervention. He was being treated 
primarily for pain and accessed physiotherapy services through 
the hospices. Michael was admitted to inpatient care at the 
hospice following a hospital stay. He died in the hospice three 
months after his first referral
Sessions 1, 2 and 3 covered only Module A, and took place over a 
longer‑than‑specified period of time (7 weeks): patient died two 
weeks later
Table 3 Descriptive data for outcome and psychological flexibility at baseline (full sample)
a FACIT‑PAL sub‑scales (higher scores indicate better quality of life)
b Higher score indicates more distress
c Higher score indicates more psychological flexibility
d No data available for one participant (Daniel)
Full sample Intervention completers 
(n = 5)









Quality of  lifea
 Physical 0 – 28 13.48 6.32 15.2 7.36 11.75 5.06
 Social 0 – 28 20.44 5.19 19.68 5.57 21.2 5.37
 Emotional 0 – 24 15.35 6.47 13.2 7.01 17.5 5.68
 Functional 0 – 28 11.91 5.86 13.06 7.71 10.75 2.87
 Palliative specific 0 – 76 59.58 19.70 59.9 16.46 59.25 25.95
Distressb 0 – 10 4.42 2.40 3.6 3.05 5.25 0.96
Psychological  Flexibilityc 0 – 126 83.83 26.42 84.4 35.64 83.25 12.91
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Staff focus groups added further depth to understand-
ing acceptability issues. Staff reported that some par-
ticipants struggled with practical components, having 
expected more traditional ‘talk’ therapy. One participant 
told staff that time between sessions was essential to 
think through answers and reflections on exercises:
“…he’s [the patient] extremely intelligent…these 
questions that were asked made him have to do 
homework and have to think more, and he found 
them extremely challenging.” (FG3).
Staff talked frequently about the prevalence of distress 
and the need for psychological interventions, highlight-
ing a perceived expectation (from patients) that this will 
be supported by hospice nurses.
“…sometimes you go and patients are quite anx-
ious…you’re non-threatening…there’s a bit more of 
Fig. 2 Graphical summary of daily assessed, single‑item quality of life question (left) and psychological flexibility assessed using the BAM (right). 
Ordinary least square regression trend lines are displayed with the solid straight line; Median Absolute Deviation variance is indicated by the shaded 
area behind the data plots); dotted vertical lines indicate end of baseline phase and end of intervention phase
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an intimacy there because you’re in their house…
you’ve build that little bit of rapport…” (FG3).
However, some staff thought that public perceptions of 
hospices as only having relevance for end of life might be 
problematic:
“the people who are most likely to turn down coming 
to the hospice …[are] the people who would actually 
benefit the most…” (FG2).
Future research using the BEACHeS intervention
Participants were asked to reflect on how the BEACHeS 
intervention might evolve in the future, and there was 
a range of views expressed. Support for re-working this 
intervention for group delivery was not strong: partici-
pants felt this would have prevented in-depth discussion, 
and willingness to openly discuss the difficult emotions 
that accompany a terminal diagnosis. One participant 
described being ‘open’ to the idea and could see a poten-
tial benefit, but for another it would have been a strong 
deterrent.
“…culturally, we’re not ready for this dynamic type of 
group work. People are guarded…you know, my ill-
ness is personal to me…No, I think the one-to-one is 
much more therapeutic…” (James)
Views on the inclusion of caregivers in the intervention 
were varied, but there was not a strong appetite for their 
inclusion:
“It’s just my partner, I dinnae ken if she’d want to 
come in or no eh. She’s funny that way isn’t she?” 
(Graham)
There were mixed views from patients on whether the 
intervention should be nurse-led, with some feeling that 
psychologists were the experts:
“ I think leave the palliative care staff to do the pal-
liative care; let’s do the drug regime and let’s make 
you comfortable at night and let’s get you food, and 
leave that side of it, but leave the grey-matter stuff to 
the psychologists.” (James)
Importantly, staff felt that recruiting at hospice referral 
did not adequately capture patients at the point of psy-
chological transition, but that this occurred earlier in the 
cancer trajectory:
“…often the patients that we’ve got have already gone 
through that stage.” (FG2)
The proposed solution was to recruit from the hospital 
setting:
“the erm hospital CNS’s you know working with 
oncology and seeing cause they see them at a much 
earlier stage, they might be the people that help a bit 
earlier.” (FG2)
Sufficiently trained, these staff expressed interest in 
delivering this new intervention:
“…I think it would fit in with what we do if we had 
that proper training…” (FG2).
Discussion
We aimed to develop a manualised ACT-based coaching 
intervention for people with non-curative cancer tran-
sitioning into palliative care. We explored acceptability 
and initial effectiveness for improving quality of life and 
distress.
Table 4 Tau‑U statistical analysis of changes in daily assessed quality of life (single‑item) and psychological flexibility (BAM)
* indicates a statistically significant change between intervention phase in the desired direction
** indicates a statistically significant change contrary to expected direction of effect
Quality of Life Psychological flexibility
Baseline to intervention Intervention to follow-up Baseline to intervention Intervention 
to follow-up















p =  < .01**








Andrew Tau‑U = .29
p = .16
Missing data Tau‑U = .29
p = .16
Missing data
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With relatively minor modifications, we were able to 
use existing ACT metaphors and exercises to ensure suit-
ability for palliative care populations. Participants’ quali-
tative data indicated intervention acceptability, and our 
50% completion rate is in line with other research [15]. 
Participants reported that they learned useful emotion 
management techniques and appreciated the space to 
talk about worries and fears. Some individual preferences 
against specific metaphors and exercises emphasises the 
need for alternative content options, though the broad 
use of metaphor was acceptable.
Though designed for weekly delivery, this was not 
practicable; in the context of rapid and unpredict-
able health status changes, flexibility is essential. For 
some, this may mean a less rigid delivery schedule over 
a greater number of weeks; for others a more inten-
sive delivery over a shorter period of time. Flexibility 
around setting may also be beneficial to reduce burden 
Fig. 3 Graphical summary of weekly assessed outcomes (left) and sub‑components of psychological flexibility (right) with module topic specified 
per participant
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of travel or resistance to visiting the hospice setting. 
Given the growth of telehealth over the past year, it 
may also be useful to consider virtual delivery via tel-
ephone or video conferencing.
Our sample had poorer baseline quality of life than 
comparative samples [28]. Still, weekly assessments 
demonstrated preliminary evidence for a positive effect 
on this outcome. Distress remained stable for most: as 
a tentative hypothesis, we believe our intervention may 
have buffered against the increased distress often associ-
ated with physical health deterioration [5]. Our expected 
increase in psychological flexibility was not demon-
strated, but this may be because of inadequate follow-up 
duration.
Daily assessment data failed to robustly demonstrate 
the statistically significant Tau-U effects that we would 
hope from SCED studies. We believe this may, in part 
at least, be due to measurement floor and ceiling effects. 
The complexity of palliative care[40] might mean that 
daily assessments are over-sensitive and traditional 
approaches of recording outcomes as a calculated ‘aver-
age’ over a set-period of time might be more psychomet-
rically informative.
Strengths and limitations
Our intervention was designed to have long-term cost-
effectiveness through brevity and manualisation, com-
paring favourably against other ACT trials in palliative 
care [13, 16]. Rather than progressing straight to a feasi-
bility trial, we developed the intervention in an empirical 
and evidence-based way using integrated mixed-meth-
ods. Doing this using an established and real-world deliv-
ery (SCED) method enabled us to demonstrate safety, 
acceptability and tentative efficacy. We ensured optimal 
likelihood of success by assessing the competency of 
facilitators, and rates of attrition and missing data were 
all positively indicated.
There are limitations. First, we did not include outcome 
assessment after the follow-up session. Second, we were 
unable to recruit partial-completers to the qualitative 
interview; most died prior to invitation. In future tri-
als, this feedback would be beneficial. Third, as outlined 
above, we had some issues with our measures. Finally, 
there was a bias towards recruitment of an already 
accepting, low-distress sample.
Implications
SCEDs do not require a control group, but without this it 
is premature to conclude that outcome improvements are 
a direct result of our intervention. These data, however, 
certainly support further testing using designs incorpo-
rating randomisation and blinding. Such work should 
aim to investigate the distress-buffering hypothesis gen-
erated from our interpretation of weekly assessments.
Our work highlights important methodological consid-
erations for future psychological intervention research 
in palliative settings. Given that our recruitment rates 
were lower than anticipated, future trials may wish to 
extend recruitment beyond only people with cancer for 
added generalizability and potential population capture. 
Despite staff buy-in, 42 otherwise eligible patients were 
not invited to participate; clinical gatekeeping is an often-
reported research barrier [41] which must be overcome.
Our four-month life-expectancy eligibility criteria (a) 
excluded many hospice referrals, and (b) did not effec-
tively reduce attrition. Recruitment earlier in the treat-
ment pathway is, therefore, recommended, for example 
by shifting the point of study recruitment to the hospi-
tal setting at the point of diagnosis of incurable disease, 
rather than after a hospice-care referral has been made. 
Provision at this earlier time point would enable partici-
pants to make better and longer use of the skills learnt, 
particularly before the more unpredictable end of life 
phase begins, and may offer broader benefit to those 
who may be reluctant to otherwise engage with hospice 
services.
For those with stable illness, intervention completion 
rates were high. However, trial length was problematic 
for those with deteriorating health. Alternative, com-
pressed, delivery is worthy of investigation, though this 
raises challenges related to homework and skill practice. 
Furthermore, those who completed the intervention were 
typically lower in distress at baseline; future work should 
recruit a sample with higher distress at baseline in whom 
higher efficacy might be hypothesised.
Regarding delivery and content, two final points are 
noteworty. First, whilst our intervention is reasonably 
pitched for adults, changes to presentation and content 
might be needed for younger populations. Second, our 
use of highly-trained psychological therapists is infeasi-
ble for long-term implementation: future research should 
explore whether fidelity and efficacy are maintained in 
delivery by other members of the healthcare team.
Conclusion
Our data adds to the growing evidence base support-
ing the use of ACT for people with advanced cancer. We 
successfully developed an acceptable intervention, and 
demonstrated some level of initial effectiveness. We have 
demonstrated the utility (and challenges) of using SCEDs 
in this setting, notwithstanding some measurement 
issues. We are planning a feasibility trial of this interven-
tion with an adapted design to improve recruitment and 
attrition rates.
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